CN103191095A - 一种stat3信号通路小分子抑制剂及其应用 - Google Patents
一种stat3信号通路小分子抑制剂及其应用 Download PDFInfo
- Publication number
- CN103191095A CN103191095A CN2013101143578A CN201310114357A CN103191095A CN 103191095 A CN103191095 A CN 103191095A CN 2013101143578 A CN2013101143578 A CN 2013101143578A CN 201310114357 A CN201310114357 A CN 201310114357A CN 103191095 A CN103191095 A CN 103191095A
- Authority
- CN
- China
- Prior art keywords
- stat3
- signal path
- cell
- halogenated aryl
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310114357.8A CN103191095B (zh) | 2013-04-02 | 2013-04-02 | 一种stat3信号通路小分子抑制剂及其在制备抗肿瘤药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310114357.8A CN103191095B (zh) | 2013-04-02 | 2013-04-02 | 一种stat3信号通路小分子抑制剂及其在制备抗肿瘤药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191095A true CN103191095A (zh) | 2013-07-10 |
CN103191095B CN103191095B (zh) | 2016-08-03 |
Family
ID=48714034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310114357.8A Expired - Fee Related CN103191095B (zh) | 2013-04-02 | 2013-04-02 | 一种stat3信号通路小分子抑制剂及其在制备抗肿瘤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191095B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606189A (zh) * | 2015-01-08 | 2015-05-13 | 苏州大学 | 一种化合物在制备mTOR抑制剂中的应用 |
CN104958288A (zh) * | 2015-06-26 | 2015-10-07 | 苏州大学 | 一种血小板抑制剂及其在制备抗血小板疾病药物中的应用 |
CN106544414A (zh) * | 2016-10-09 | 2017-03-29 | 广州泰诺迪生物科技有限公司 | 一种检测肺癌脑转移样本中stat3和lck的方法 |
CN111662288A (zh) * | 2020-06-23 | 2020-09-15 | 徐州医科大学 | 一种抑制akt与stat3活性的小分子化合物及其应用 |
CN117599030A (zh) * | 2023-12-08 | 2024-02-27 | 上海交通大学医学院 | 小分子sc99在制备抗新型冠状病毒药物中的应用 |
-
2013
- 2013-04-02 CN CN201310114357.8A patent/CN103191095B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
张大永 等: "STAT3抑制剂及其抗肿瘤活性研究进展", 《药学进展》, vol. 36, no. 7, 31 July 2012 (2012-07-31), pages 289 - 297 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606189A (zh) * | 2015-01-08 | 2015-05-13 | 苏州大学 | 一种化合物在制备mTOR抑制剂中的应用 |
CN104958288A (zh) * | 2015-06-26 | 2015-10-07 | 苏州大学 | 一种血小板抑制剂及其在制备抗血小板疾病药物中的应用 |
CN106544414A (zh) * | 2016-10-09 | 2017-03-29 | 广州泰诺迪生物科技有限公司 | 一种检测肺癌脑转移样本中stat3和lck的方法 |
CN111662288A (zh) * | 2020-06-23 | 2020-09-15 | 徐州医科大学 | 一种抑制akt与stat3活性的小分子化合物及其应用 |
CN111662288B (zh) * | 2020-06-23 | 2022-06-14 | 徐州医科大学 | 一种抑制akt与stat3活性的小分子化合物及其应用 |
CN117599030A (zh) * | 2023-12-08 | 2024-02-27 | 上海交通大学医学院 | 小分子sc99在制备抗新型冠状病毒药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103191095B (zh) | 2016-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | 15‐deoxy‐∆‐12, 14‐prostaglandin J2 (15d‐PGJ2), an endogenous ligand of PPAR‐γ: Function and mechanism | |
CN103191095B (zh) | 一种stat3信号通路小分子抑制剂及其在制备抗肿瘤药物中的应用 | |
CN105111271B (zh) | 一种熊果酸-阿司匹林偶联物及其在制备预防肿瘤转移药物中的应用 | |
Wang et al. | CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma | |
CN103845314A (zh) | 一种丹参新酮在制备抗肿瘤药物中的应用 | |
CN104398526A (zh) | 雷公藤甲素和雷公藤红素在制备抗肿瘤药物中的应用 | |
Wang et al. | Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways | |
Xu et al. | Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage‐Mediated Lung Cancer in Mice | |
Liu et al. | Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis | |
JP2015501792A (ja) | ベンジリデンベンゾヒドラジドを用いた卵巣がんの治療 | |
Wu et al. | Trichinella spiralis muscle larvae excretory/secretory products trigger apoptosis and S-phase arrest of the non-small-cell lung cancer line A549 | |
CN108338983B (zh) | 乙酰华蟾毒精在制备治疗肿瘤药物中的应用 | |
Huo et al. | Inhibitory effect and mechanism of metformin on human ovarian cancer cells SKOV-3 and A2780 | |
Tan et al. | Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm‐Coagulation‐Blood‐Stasis Syndrome via the STAT3/Cyclin D1 Pathway | |
CN106822904B (zh) | 含akt抑制剂和ire1抑制剂的药物组合物及其应用 | |
CN104586873A (zh) | 木蝴蝶苷a在制备治疗癌症药物中的应用 | |
Huang et al. | The crucial roles and research advances of cGAS-STING pathway in cutaneous disorders | |
CN104592182A (zh) | 一种咖啡酸苯乙酯类化合物及其制备方法及应用 | |
CN105213366A (zh) | 藤黄酮化合物的医药用途及其药物组合物 | |
CN113876761B (zh) | 磷酸二酯酶4抑制剂ZL-n-91在制备抗骨肉瘤药物中的应用 | |
CN107987054A (zh) | 一种新型cdk2抑制剂及其抗乳腺癌的应用 | |
CN114159441A (zh) | Gsk126在制备治疗奥沙利铂耐药结肠癌药物中的应用 | |
TWI671284B (zh) | 治療大腸直腸癌的化合物 | |
CN101199534B (zh) | 一种原人参二醇衍生物的抗肿瘤用途 | |
CN103536605A (zh) | 抗hiv药物安瑞那韦在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: Suzhou City, Jiangsu province 215137 Xiangcheng District Ji Road No. 8 Patentee after: Soochow University Address before: 215123 Suzhou City, Suzhou Province Industrial Park, No. love road, No. 199 Patentee before: Soochow University |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200427 Address after: Room 947-5, block a, phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1, xinjinhu Road, Jiangbei new district, Nanjing City, Jiangsu Province Patentee after: Jiangsu Jicui Institute of medical immunology Co.,Ltd. Address before: 210000 Room 411, floor 4, building 02, accelerator phase II, No. 11, Yaogu Avenue, Jiangbei new district, Nanjing, Jiangsu Province Patentee before: Nanjing Medical Chuangxing Intellectual Property Service Co.,Ltd. Effective date of registration: 20200427 Address after: 210000 Room 411, floor 4, building 02, accelerator phase II, No. 11, Yaogu Avenue, Jiangbei new district, Nanjing, Jiangsu Province Patentee after: Nanjing Medical Chuangxing Intellectual Property Service Co.,Ltd. Address before: Suzhou City, Jiangsu province 215137 Xiangcheng District Ji Road No. 8 Patentee before: SOOCHOW University |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160803 |
|
CF01 | Termination of patent right due to non-payment of annual fee |